RUSTON, La. (KNOE) - Louisiana Tech University students are trying to help people with diabetes. The group Polar Case developed a diabetes kit they say has heating and cooling technology that others don't.
The team created a diabetes kit that is compact enough that people can carry it anywhere. More importantly, it's temperature controlled.
“It was a really good experience, so it was kind of like a dream come true,” says Joseph Brunet.
Brunet is part of the team comprised of Mechanical Engineering and Business students. The team won the university’s Top Dog New Venture Championship and thousands of dollars to continue developing their proof of concept.
“It automatically controls the temperature with an electric temperature control unit that we designed,” says Carli Whitfield, a member of Polar Case. “And it also has some lights on it that display whether or not it's being heated or cooled as well as the remaining battery life."
They say the product is designed to hold all the necessary supplies a diabetic needs daily. They say the Polar Case kit gives users more flexibility to be outdoors in any temperature.
“My little brother was diagnosed with type 1 diabetes when he was 17 months old, and he's ten now,” says Whitfield, “And then, my dad just last year was diagnosed with type 1."
She says she’s watched the struggles of her family members trying to keep their supplies at room temperature, and that’s what sparked the idea.
Whitfield says thanks to online surveys they were able to narrow down what's inside the kit, like insulin pens, meters, strips, pen tips, a lancing device, glucagon, and extra supplies.
Arman Hajiesmaeili - another member of Polar Case - says now they'll turn to social media to market it.
“We want to give doctors and maybe some bloggers the free product so they can actually test it,” says Hajiesmaeili.
He says as an international student he hopes to take this product worldwide. The rest of the team says the future is pretty bright, too.
“I think in the future it won't just be for diabetics, you know we're hoping to move into other markets,” says Brunet. “There's EpiPens, there's tons of medication besides those two that could use this technology."
The team says they've already met with investors and plan to continue developing their diabetes kit after graduation